Hematology and Medical Oncology

As part of Emory University School of Medicine and Winship Cancer Institute, the faculty in the Department of Hematology and Medical Oncology are leaders in cancer research activity, providing the latest therapies for patient care, and training the next generation of hematologists and medical oncologists.

Welcome to Hematology and Medical Oncology

The Department of Hematology and Medical Oncology is focused on clinical and basic research, education, and delivering outstanding hematology and oncology clinical services to patients.

Message from the Chair

Dr. Sagar Lonial with patient in clinic room

Divisions

Research Areas

Our faculty consist of clinical and basic science investigators who conduct a broad range of basic, translational and clinical research on a variety of human malignancies. Through novel discoveries, we are leading the way to a better understanding and improved detection and treatment of cancer.

Fellowship Program

The Hematology and Medical Oncology Fellowship Program offered by Emory University School of Medicine and Winship Cancer Institute of Emory University is a 3-year ACGME-accredited graduate medical education program.

Medical oncology fellows walking down hall on inpatient floor.

Winship Cancer Institute of Emory University

Winship Cancer Institute of Emory University is Georgia's only National Cancer Institute-designated comprehensive cancer center and serves as the coordinating center for cancer research, education and care throughout Emory University.

Upcoming Symposium

Each summer, Winship hosts the Debates and Didactics in Hematology and Oncology Conference (DDHO). The conference features a comprehensive review into mechanisms of disease and treatments for patients with cancer or blood disorders. Save the date for next year's conference to be held July 20-23, 2023 at Sea Island, Georgia.

>>Visit DDHO website.

2023 Debates and Didactics in Hematology and Oncology Conference

News

Winship News

New AI-based biomarker can help predict immunotherapy response for patients with lung cancer Jan. 4, 2023

Winship Cancer Institute researchers and colleagues from several health care systems and universities have discovered a new AI-derived biomarker that uses routine imaging scans to help predict which patients with lung cancer will respond to immunotherapy.

Cooling glioblastoma to room temperature extends survival in preclinical study Dec. 14, 2022

A new preclinical study recently reported in Science Advances and led by Emory University and UT Southwestern Medical Center researchers suggests that cooling brain tumors to room temperature may extend survival of patients with glioblastoma multiforme.

Study finds Black women have worst HR+/HER2- breast cancer outcomes of all racial and ethnic groups Dec. 6, 2022

Winship breast oncologist Kevin Kalinsky, MD, MS, shared RxPONDER trial results at the 2022 San Antonio Breast Cancer Symposium showing Black women with HR+/HER2- breast cancer have worse outcomes than other racial and ethnic groups.

Events

Main Calendar

Loading Events...